Radiopharm Theranostics (ASX:RAD) Total Operating Expense : A$41.57 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Total Operating Expense?

Radiopharm Theranostics's Total Operating Expense for the six months ended in Dec. 2023 was A$24.70 Mil. Radiopharm Theranostics's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$41.57 Mil.

Radiopharm Theranostics Total Operating Expense Historical Data

The historical data trend for Radiopharm Theranostics's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Total Operating Expense Chart

Radiopharm Theranostics Annual Data

Trend

Jun22

Jun23

Total Operating Expense

19.93

34.80

Radiopharm Theranostics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Total Operating Expense	9.64	10.29	17.93	16.87	24.70

Radiopharm Theranostics Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$41.57 Mil.

Radiopharm Theranostics Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Radiopharm Theranostics (ASX:RAD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

RDPTF:USA

Address

62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053

Website

https://www.radiopharmtheranostics.com

Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (ASX:RAD) Headlines

No Headlines